Provided by Tiger Trade Technology Pte. Ltd.

Agilent

125.81
+0.93000.74%
Post-market: 125.810.00000.00%17:25 EST
Volume:1.53M
Turnover:192.41M
Market Cap:35.61B
PE:27.53
High:127.77
Open:125.60
Low:125.02
Close:124.88
52wk High:160.27
52wk Low:96.43
Shares:283.05M
Float Shares:283.00M
Volume Ratio:0.65
T/O Rate:0.54%
Dividend:0.99
Dividend Rate:0.79%
EPS(TTM):4.57
EPS(LYR):4.59
ROE:20.62%
ROA:8.48%
PB:5.28
PE(LYR):27.42

Loading ...

DBGI Announces Purchase of Existing Convertible Notes and Note Conversion Extension by Holders

GlobeNewswire
·
Yesterday

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement

GlobeNewswire
·
Yesterday

Press Release: Figure Technology Solutions Announces Preliminary Fourth Quarter & Full Year 2025 Financial Results

Dow Jones
·
Feb 13

Calendar of Canada Earnings Expected in the Week Ahead

Dow Jones
·
Feb 12

Quietly Powerful: Hoymiles HoyUltra 2 C&I ESS Achieves Breakthrough ≤60 dB(A) in Certified Noise Testing

prnewswire
·
Feb 12

Agilent gets FDA approval for PD-L1 IHC 22C3 pharmDx

TIPRANKS
·
Feb 12

Oak Woods Acquisition Corporation Announces Receipt of Nasdaq Staff Delisting Determination

GlobeNewswire
·
Feb 12

Revvity Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Feb 12

Press Release: Agilent Announces Cash Dividend of 25.5 Cents per Share

Dow Jones
·
Feb 12

BRIEF-Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award

Reuters
·
Feb 11

Agilent's Ovarian Cancer Diagnostic Test Receives FDA Clearance

MT Newswires Live
·
Feb 11

Agilent Receives FDA Approval for Pd-L1 Ihc 22C3 Pharmdx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (Eoc)

THOMSON REUTERS
·
Feb 11

FDA Approves Agilent PD-L1 Test for First-Line Ovarian Cancer Therapy

Reuters
·
Feb 11

FDA Approves Pembrolizumab With Paclitaxel For Platinum-Resistant Epithelial Ovarian, Fallopian Tube, Primary Peritoneal Carcinoma

Reuters
·
Feb 11

ScanTech AI Systems Inc. Announces Nasdaq Delisting Determination, Pending Trading Suspension, and Intent to Seek OTCQB Quotation

GlobeNewswire
·
Feb 10

Agilent Technologies Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Feb 10

ProQR Announces Planned Changes to Board Composition

GlobeNewswire
·
Feb 09

COUNTRY GARDEN Issues 123 Million Shares Following Conversion of Mandatory Convertible Bonds

Stock News
·
Feb 09

Agilent (A) Gets a Buy from Barclays

TIPRANKS
·
Feb 09

Agilent’s SLAS2026 Automation Push Might Change The Case For Investing In Agilent Technologies (A)

Simply Wall St.
·
Feb 07